Prot #CO-338-085: ATLAS: A Phase 2, Open-label Study of Rucaparib in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

  • Morgans, Alicia Katherine (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date5/29/186/30/22

Funding

  • SynteractHCR, Inc. (Prot #CO-338-085)
  • Clovis Oncology, Inc. (Prot #CO-338-085)